MedTrace Logo

A Reduction in C-section Rates Using the Hem-Avert Perianal Stabilizer

NCT01739543 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2013-03-18

No results posted yet for this study

Summary

A REDUCTION IN C-SECTION RATES USING THE HEM-AVERT® PERIANAL STABILIZER.

Conditions

  • Complications; Cesarean Section

Interventions

DEVICE

Hem-Avert

Application of Hem-Avert

Sponsors & Collaborators

  • Stetrix, Inc.

    lead INDUSTRY

Principal Investigators

  • Dan Burns, M.D. · Unafilliated

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01739543 on ClinicalTrials.gov